Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...
After BioAge Labs raised nearly $200 million in its IPO this week, several companies are beginning to eye the public markets, ...
BioAge Labs is bringing in almost $200 million via its Nasdaq IPO this morning, with the proceeds earmarked for taking its ...
(Reuters) -BioAge Labs is eyeing a valuation of up to $639.7 million in its upsized initial public offering in the United ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback